Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three NDAs. There are three patents protecting this compound.
Drug patent litigation for BORTEZOMIB.
This ingredient has four patent family members in four countries.
Three suppliers are listed for this compound. There are twelve tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com